Skip to main content

Updated Guidance Issued for Managing Lower-Extremity Peripheral Artery Disease

Medically reviewed by Carmen Pope, BPharm. Last updated on May 20, 2024.

By Elana Gotkine HealthDay Reporter

MONDAY, May 20, 2024 -- In a clinical practice guideline issued by the American Heart Association, the American College of Cardiology, and nine other medical societies, updated recommendations are presented for the management of lower-extremity peripheral artery disease (PAD). The guideline was published online May 14 simultaneously in Circulation and the Journal of the American College of Cardiology.

Heather L. Gornik, M.D., from the University Hospitals Harrington Heart & Vascular Institute in Cleveland, and colleagues note that PAD is a common cardiovascular disease associated with the risk for amputation, myocardial infraction, stroke, and death. Four clinical subsets of PAD were defined: asymptomatic PAD, chronic symptomatic PAD, chronic limb-threatening ischemia, and acute limb ischemia. In most patients, PAD is detected through history, physical examination, and resting ankle-brachial index. Health disparities can lead to poor limb and cardiovascular outcomes, which should be addressed at the individual patient and population level.

For patients with PAD, the researchers recommend effective medical therapies should be prescribed to prevent major adverse cardiovascular events and major adverse limb events; these include antiplatelet and antithrombotic therapy, lipid-lowering and antihypertensive therapy, diabetes management, and smoking cessation. For people not at increased risk for bleeding, rivaroxaban plus low-dose aspirin is effective. Structured exercise is a core component of PAD care. For patients with chronic limb-threatening ischemia, revascularization should be used to prevent limb loss; this can also improve quality of life and functional status in patients with claudication not responsive to medical therapy and structured exercise.

"It's important to recognize the signs and symptoms of PAD and move quickly to initiate treatment to improve outcomes and reduce risks," Gornik said in a statement.

Several authors disclosed ties to the biopharmaceutical and medical device industries.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted May 2024

Read this next

Heart Attack Survivorship Tied to Long-Term Health Consequences

MONDAY, March 4, 2024 -- Heart attacks are associated with an increased risk for developing other serious health conditions, such as peripheral arterial disease, renal failure...

Black Patients With Peripheral Artery Disease Have Worse Outcomes

TUESDAY, July 18, 2023 -- There are significant racial disparities in the diagnosis, treatment, and outcomes of peripheral artery disease (PAD), according to a study recently...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.